Spero Therapeutics Inc (NASDAQ:SPRO)

10.41
Delayed Data
As of May 25
 -0.17 / -1.61%
Today’s Change
9.66
Today|||52-Week Range
19.00
-11.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

--
Revenue and IncomeNet Revenues0.00335.0K2.0M--
 
 
 
Depreciation And Amortization11.0K279.0K363.0K--
 
 
 
 
 
Operating ExpensesGross Income-11.0K------
 
 
General Expenses13.3M33.3M43.3M--
 
 
 
 
Research And Development11.1M26.3M32.9M--
 
 
 
 
Total Operating Expenses13.3M33.6M43.7M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.3M-33.2M-41.7M--
 
 
 
 
Extraordinary Credit174.0K580.0K1.5M--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.2M-32.6M-39.9M--
 
 
 
 
Minority Interest-3.0M-7.2M-1.1M--
 
 
 
 
Preferred Dividend-3.3M-4.4M-7.4M--
 
 
 
 
Net Income-10.2M-25.5M-38.7M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.7M14.7M2.6M--
 
 
 
 
Shares To Calculate EPS Diluted14.7M14.7M2.6M--
 
 
 
 
 
Earnings Per ShareEPS-$0.91-$2.03-$17.82--
 
 
 
 
EPS Diluted-$0.91-$2.03-$17.82--